e-learning
resources
Barcelona 2010
Monday, 20.09.2010
COPD and asthma: models and human studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heat shock proteins and FKBP51 expression in sputum cells of COPD patients during formoterol/budesonide/theophylline therapy
R. Mroz, A. Holownia, E. Chyczewska, J. Braszko (Poland)
Source:
Annual Congress 2010 - COPD and asthma: models and human studies
Session:
COPD and asthma: models and human studies
Session type:
E-Communication Session
Number:
1994
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Mroz, A. Holownia, E. Chyczewska, J. Braszko (Poland). Heat shock proteins and FKBP51 expression in sputum cells of COPD patients during formoterol/budesonide/theophylline therapy. Eur Respir J 2010; 36: Suppl. 54, 1994
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Increased expression of heat shock protein 70 in COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Heat shock protein (HSP) 72 polymorphism in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005
Serum heat shock protein 47 levels in patients with drug induced lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Heat shock protein expression in small cell lung cancer (SCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Spontaneous and mycobacterial heat shock proteins – induced apoptosis of monocytes in sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Heat shock protein (HSP) 72 polymorphism in small cell lung cancer (SCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005
Mycobacterial heat shock proteins in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Increased sputum FKBP51 gene expression following Azithromycin add-on therapy in asthma
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018
Increased circulating heat shock protein 70 levels in pregnant asthmatics
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010
Heat shock proteins (HSP)-10 and –40 increase in bronchial biopsies of patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002
Extracorporeal shock waves increase markers of cellular proliferation in primary bronchial fibroblasts of COPD patients
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Downregulation of the pro-apototic gene, BNIPL, in bronchial biopsies from COPD patients
Source: ERS Lung Science Conference 2017
Year: 2017
Expression of selected surface markers on macrophages in induced sputum from patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Extracellular Hsp70 modulates inflammatory response in PBEC cells from COPD patients
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Expression of c-inhibitor of apoptosis protein-2 in the sputum from asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001
Expression of MAGE in the induced sputum of lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002
Immunocytochemistry evaluation of FKBP51 in induced sputum cells as a biomarker of glucocorticoid therapy in asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept